Advances in the use of nanocarriers for cancer diagnosis and treatment

Detalhes bibliográficos
Autor(a) principal: Vieira,Débora Braga
Data de Publicação: 2016
Outros Autores: Gamarra,Lionel Fernel
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Einstein (São Paulo)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082016000100099
Resumo: ABSTRACT The use of nanocarriers as drug delivery systems for therapeutic or imaging agents can improve the pharmacological properties of commonly used compounds in cancer diagnosis and treatment. Advances in the surface engineering of nanoparticles to accommodate targeting ligands turned nanocarriers attractive candidates for future work involving targeted drug delivery. Although not targeted, several nanocarriers have been approved for clinical use and they are currently used to treat and/or diagnosis various types of cancers. Furthermore, there are several formulations, which are now in various stages of clinical trials. This review examined some approved formulations and discussed the advantages of using nanocarriers in cancer therapy.
id IIEPAE-1_853b7861377a3c44093f27a24ccdcdcd
oai_identifier_str oai:scielo:S1679-45082016000100099
network_acronym_str IIEPAE-1
network_name_str Einstein (São Paulo)
repository_id_str
spelling Advances in the use of nanocarriers for cancer diagnosis and treatmentNanomedicineLiposomesNanoparticlesNeoplasms/drug therapyDrug delivery systemsABSTRACT The use of nanocarriers as drug delivery systems for therapeutic or imaging agents can improve the pharmacological properties of commonly used compounds in cancer diagnosis and treatment. Advances in the surface engineering of nanoparticles to accommodate targeting ligands turned nanocarriers attractive candidates for future work involving targeted drug delivery. Although not targeted, several nanocarriers have been approved for clinical use and they are currently used to treat and/or diagnosis various types of cancers. Furthermore, there are several formulations, which are now in various stages of clinical trials. This review examined some approved formulations and discussed the advantages of using nanocarriers in cancer therapy.Instituto Israelita de Ensino e Pesquisa Albert Einstein2016-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082016000100099einstein (São Paulo) v.14 n.1 2016reponame:Einstein (São Paulo)instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)instacron:IIEPAE10.1590/S1679-45082016RB3475info:eu-repo/semantics/openAccessVieira,Débora BragaGamarra,Lionel Ferneleng2016-04-05T00:00:00Zoai:scielo:S1679-45082016000100099Revistahttps://journal.einstein.br/pt-br/ONGhttps://old.scielo.br/oai/scielo-oai.php||revista@einstein.br2317-63851679-4508opendoar:2016-04-05T00:00Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)false
dc.title.none.fl_str_mv Advances in the use of nanocarriers for cancer diagnosis and treatment
title Advances in the use of nanocarriers for cancer diagnosis and treatment
spellingShingle Advances in the use of nanocarriers for cancer diagnosis and treatment
Vieira,Débora Braga
Nanomedicine
Liposomes
Nanoparticles
Neoplasms/drug therapy
Drug delivery systems
title_short Advances in the use of nanocarriers for cancer diagnosis and treatment
title_full Advances in the use of nanocarriers for cancer diagnosis and treatment
title_fullStr Advances in the use of nanocarriers for cancer diagnosis and treatment
title_full_unstemmed Advances in the use of nanocarriers for cancer diagnosis and treatment
title_sort Advances in the use of nanocarriers for cancer diagnosis and treatment
author Vieira,Débora Braga
author_facet Vieira,Débora Braga
Gamarra,Lionel Fernel
author_role author
author2 Gamarra,Lionel Fernel
author2_role author
dc.contributor.author.fl_str_mv Vieira,Débora Braga
Gamarra,Lionel Fernel
dc.subject.por.fl_str_mv Nanomedicine
Liposomes
Nanoparticles
Neoplasms/drug therapy
Drug delivery systems
topic Nanomedicine
Liposomes
Nanoparticles
Neoplasms/drug therapy
Drug delivery systems
description ABSTRACT The use of nanocarriers as drug delivery systems for therapeutic or imaging agents can improve the pharmacological properties of commonly used compounds in cancer diagnosis and treatment. Advances in the surface engineering of nanoparticles to accommodate targeting ligands turned nanocarriers attractive candidates for future work involving targeted drug delivery. Although not targeted, several nanocarriers have been approved for clinical use and they are currently used to treat and/or diagnosis various types of cancers. Furthermore, there are several formulations, which are now in various stages of clinical trials. This review examined some approved formulations and discussed the advantages of using nanocarriers in cancer therapy.
publishDate 2016
dc.date.none.fl_str_mv 2016-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082016000100099
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082016000100099
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1679-45082016RB3475
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
dc.source.none.fl_str_mv einstein (São Paulo) v.14 n.1 2016
reponame:Einstein (São Paulo)
instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
instname_str Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron_str IIEPAE
institution IIEPAE
reponame_str Einstein (São Paulo)
collection Einstein (São Paulo)
repository.name.fl_str_mv Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
repository.mail.fl_str_mv ||revista@einstein.br
_version_ 1752129908352483328

Registros relacionados